Press release
Cancer in the workplace: How companies can support employees
dendritic cell therapy immuno-oncology (© IMMUMEDIC Limited)
A cancer diagnosis changes life abruptly - not only for those affected, but also for those around them. The workplace in particular plays a central role during this time. More and more companies are realizing that actively supporting sick employees is not only a human gesture, but can also make good business sense.
Health is an economic factor
Around half a million people in Germany are diagnosed with cancer every year - many of them of working age. For companies, this means Skilled workers are suddenly absent, work processes have to be restructured and teams need to be relieved. An early and individually tailored offer of support can help to maintain or restore employees' ability to work more quickly.
What companies can do in concrete terms
1. offer flexible working models: Home office, part-time, flexitime or gradual reintegration.
2. promote individual health programs: Fund complementary therapies such as psychosocial counseling or immune boosting.
3. enable additional medical benefits: Subsidies for therapies such as dendritic cell therapy.
4. support long-term return: Collaborate with rehab and social services.
Dendritic cell therapy: an innovative therapeutic approach
Dendritic cell therapy is a personalized form of cancer immunotherapy in which the patient's own immune cells are loaded with tumour antigens in the laboratory and returned to the body. The aim is to specifically activate the immune system and fight tumor cells in the long term. For working cancer patients, this form of therapy is often better tolerated than traditional chemotherapy.
For entrepreneurs, supporting such innovative therapies offers the following advantages:
- Faster convalescence: patients report a better general condition, fewer side effects and greater resilience.
- Reduced absenteeism: Targeted immune activation can help prevent relapses.
- Tax deductibility: Subsidies for medically justified therapies can be recognized as business expenses.
- Image advantage: Companies that promote modern therapies position themselves as progressive and employee-oriented.
Advantages for the company
Companies that actively support employees during the health crisis benefit in several ways:
✅ Tax benefits and funding:
- Workplace health promotion (BGF) up to €600 per year tax-free (Section 3 No. 34 EStG).
- Allowances for medical treatment are considered tax-free welfare expenses.
- Reduced continued salary costs due to faster recovery.
✅ Cost reduction in the company:
- Avoidance of overtime, sickness absence and overwork in the team.
- Retention of know-how and experience - instead of cost-intensive replacement.
✅ Employee retention and improved image:
- Loyalty increases - employees feel supported.
- Companies strengthen their image as socially responsible employers.
A plea for a new corporate culture
Cancer should not mean a career break. Companies that are prepared to invest in the health of their employees not only get their workforce back - they send a strong signal of humanity that will also be rewarded economically in the long term.
IMMUMEDIC Limited
The Cell Factory
Lukasz Derbot
Jana III Sobieskiego 1
59-220 Legnica/ Poland
https://www.dendritic-cell-therapy.eu/
Herr Lukasz Derbot
+4916091942558
lukasz.derbot@gmail.com
IMMUMEDIC Limited - Competence Center for Immunotherapy
IMMUMEDIC Limited, based in Europe, is a specialized provider of therapy support, information services and treatment concepts in the field of dendritic cell therapy, complementary immunotherapy and cancer prevention. In close cooperation with specialized laboratories, clinics and research institutes, the company supports patients in navigating the complex field of biological cancer therapies.
The focal points include
- Individually tailored immunotherapy planning (e.g. DC therapy, T-cell activation, tumor-targeted strategies)
- Therapy support and aftercare advice
- Networking with international specialist centers and study sites
- Informing and educating patients about the opportunities and limitations of modern immune procedures
- Scientific publications and participation in research projects
Vision and values
Andreas Rach is convinced that modern cancer therapy should not be based solely on toxicity and destruction - but on strengthening, precision and system understanding. He is committed to therapies that activate the body's own immune system and at the same time promote quality of life and personal responsibility.
IMMUMEDIC stands for:
- Transparency and reliable information
- Individualized medical care
- Scientifically validated concepts
- International orientation with a focus on innovation
Commitment
In addition to his practical work, Andreas Rach is involved in medical journalism, the development of digital information formats for patients and networking between medical progress and patient access. With the book project "Dendritic Cell Therapy - Immunological Cancer Therapy of the Future", he is setting an example for well-founded patient education and forward-looking medicine.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer in the workplace: How companies can support employees here
News-ID: 4122155 • Views: …
More Releases from IMMU
Why waiting for a diagnosis of "metastases is dangerous?
Why waiting is dangerous - New hope for metastases through immunotherapy with dendritic cells and "ImmuSeroForte"
The appearance of metastases in cancer is a shock for many patients and their relatives. In breast cancer in particular, but also in other types of tumor, metastases are often the turning point of the disease - they can become life-threatening.
But an important message is: waiting is not an option. The faster action is taken,…
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms…
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of…
The key to fighting cancer: Dendritic cell therapy ?
In today's world, where we are constantly faced with new challenges in the field of cancer treatment, it is crucial to pursue innovative approaches. One promising method is therapy with tumor antigen-loaded dendritic cells. A functioning immune system plays a central role in fighting tumors and metastases. But how can we specifically support the immune system?
Autologous dendritic cell therapy, produced from the blood of the affected patient, offers a promising…
More Releases for IMMUMEDIC
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms…
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of…
Harness the power of your immune system with dendritic cells
In modern medicine, the understanding of the immune system and its role in the
fight against cancer is becoming increasingly important. Dendritic cells, a key component of our immune system
immune system, play a crucial role in this. These specialized immune cells are responsible for
responsible for recognizing foreign structures such as tumour cells and activating the immune system. But what
does this mean for patients suffering from cancer? And how can dendritic cells…
Can we still be cured? Can cancer be cured?
Dealing with the subject of cancer quickly reveals the complexity of this disease. The question of how to cure tumors and metastases is anything but simple. There are doctors who firmly believe in the golden standard - chemotherapy, radiotherapy or hormone therapy - and propagate these as universal solutions. Alternative therapies, on the other hand, are often stigmatized; when patients bring such approaches into play, the response is often to…
